Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
As one of the earliest pathologic changes, the aberrant re-expression of many cell cycle -related proteins and inappropriate cell cycle control in specific vulnerable neuronal populations in Alzheimer’s disease (AD) is emerging as an important component in the pathogenesis leading to AD and other neurodegenerative diseases. These events are clearly representative of a true cell cycle, rather than epiphenomena of other processes since, in AD and other neurodegenerative diseases, there is a true mitotic alteration that leads to DNA replication. While the exact role of cell cycle re-entry is unclear, recent studies using cell culture and animal models strongly support the notion that the dysregulation of cell cycle in neurons leads to the development of AD-related pathology such as hyperphosphorylation of tau and amyloid-β deposition and ultimately causes neuronal cell death. Importantly, cell cycle re-entry is also evident in mutant amyloid-β protein precursor and tau transgenic mice and, as in human disease, occurs prior to the development of the pathological hallmarks, neurofibrillary tangles and amyloid-β plaques. Therefore, the study of aberrant cell cycle regulation in model cellular and animal systems may provide extremely important insights into the pathogenesis of AD while serving as a means to test novel therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 2×
“However, in cells where the cell cycle is interrupted or dysfunctional, cells enter ‘‘phase stasis’’ with mitochondrial imbalance (Hirai et al., 2001; Wang et al., 2008), which serve as potent sources of free radicals and cause redox imbalance (Nunomura et al., 2001).”
BackgroundSelf-citationMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 2×
“However, in cells where the cell cycle is interrupted or dysfunctional, cells enter ‘‘phase stasis’’ with mitochondrial imbalance (Hirai et al., 2001; Wang et al., 2008), which serve as potent sources of free radicals and cause redox imbalance (Nunomura et al., 2001).”
BackgroundSelf-citationPhosphorylation affects the ability of tau protein to promote microtubule assembly.
Lindwall, G., & Cole, R. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42989-9 · Cited by 901 · cited 1×
“The increased phosphorylation of tau destabilizes microtubular dynamics and, consequently, results in neuronal dysfunction (Lindwall and Cole, 1984; Alonso et al., 1996; Delacourte, 2006).”
BackgroundCell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4637-04.2005 · Cited by 511 · cited 3×
“Interestingly, a recent transgenic mice study demonstrated that the overexpression of normal human tau protein induces neuronal apoptosis and cell cycle re-entry (Andorfer et al., 2005).”
BackgroundInfluentialAlzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal
Hardy, J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s317 · Cited by 475 · cited 2×
“precursor, the amyloid-b precursor protein (AbPP), encoded on chromosome 21 (Hardy, 2006; Masters and Beyreuther, 2006).”
BackgroundInfluentialZhu, X., Rottkamp, C. A., Boux, H., Takeda, A., Perry, G., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.880 · Cited by 378 · cited 1×
“…non-dividing state (Arendt et al., 1995, 1996, 1998; Smith and Lippa, 1995; McShea et al., 1997, 1999a,b; Nagy et al., 1997a,b; Vincent et al., 1996, 1997, 1998; Raina et al., 1999a,b, 2000a,b; Zhu et al., 1999, 2000a,b,c, 2004; Ogawa et al., 2003; Previll et al., 2007; Thakur et al., 2008).”
Self-citationThe pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611671104 · Cited by 276 · cited 3×
“Furthermore, injection of dopaminergic neurotoxin 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into mice, which has been widely used as a model of Parkinson’s disease, activates the retinoblastoma-E2F pathway in postmitotic dopaminergic neurons (Hoglinger et al., 2007).”
BackgroundTOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model
Khurana, V., Lu, Y., Steinhilb, M. L., Oldham, S., Shulman, J. M., & Feany, M. B. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.042 · Cited by 266
Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimerʼs disease
Lars Rödel, T. A., Gärtner, U., & Holzer, M. (1996) · NeuroReport · doi:10.1097/00001756-199611250-00050 · Cited by 250
Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease
Arendt, T., Holzer, M., & Gärtner, U. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050104 · Cited by 137
Expression Patterns of Retinoblastoma Protein in Parkinson Disease
Jordan-Sciutto, K. L., Dorsey, R., Chalovich, E. M., Hammond, R. R., & Achim, C. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.68 · Cited by 121
Weber, T., Corbett, M. K., Chow, L. M. L., Valentine, M. B., Baker, S. J., & Zuo, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708061105 · Cited by 89
Cited by
Suberbielle, E., Sanchez, P. E., Kravitz, A. V., Wang, X., Ho, K., Eilertson, K., Devidze, N., Kreitzer, A. C., & Mucke, L. (2013) · Nature Neuroscience · doi:10.1038/nn.3356 · Cited by 487
Butterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403
Golde, T. E., & Miller, V. M. (2009) · Alzheimer's Research & Therapy · doi:10.1186/alzrt5 · Cited by 98
Sanphui, P., Pramanik, S. K., Chatterjee, N., Moorthi, P., Banerji, B., & Biswas, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078842 · Cited by 38
“However, in AD, accumulating evidence suggests that neurons vulnerable to degeneration emerge from non-dividing state to cycling state with expression/activation of cell cycle markers [5,6,7,8].”
BackgroundWidespread genotype-phenotype correlations in intellectual disability
Casanova, E. L., Gerstner, Z., Sharp, J. L., Casanova, M. F., & Feltus, F. A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00535 · Cited by 31
“Nuclear localization appears to be a strong risk factor in the developments of both autism and CFD in these subgroups; however, cell cycle involvement may provide an additional risk for NLF as we see in many classical neurodegenerative diseases (28).”
Background
Metadata
- Authors
- Lee, H.-G., Casadesus, G., Zhu, X., Castellani, R. J., McShea, A., Perry, G., Petersen, R. B., Bajic, V., & Smith, M. A.
- Venue
- Neurochemistry International
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 54
- Issue
- 2
- Pages
- 84-88
- ISSN
- 0197-0186 (ISSN-L)
- OpenAlex
- W2032195804
- Cited by
- 131
- References
- 13
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.